{"disease":{"id":"treatment-of-osteoporosis-in-postmenopausal-women-at-high-risk-of-fracture-treatment-to-increase-bone-mass-in-men-with-osteoporosis-treatment-to-increase-bone-mass-in-women-with-osteoporosis-due-to-sustained-systemic-glucocorticoid-therapy-treatment-of-bone-loss-associated-with-hormone-ablation-in-men-with-prostate-cancer-treatment-of-bone-loss-in-women-with-breast-cancer-treatment-of-giant-cell-tumor-of-bone-treatment-of-hypercalcemia-of-malignancy-treatment-of-multiple-myeloma-treatment-of-bone-metastases-in-men-with-prostate-cancer-treatment-of-bone-metastases-in-women-with-breast-cancer.md","name":"treatment of osteoporosis in postmenopausal women at high risk of fracture treatment to increase bone mass in men with osteoporosis treatment to increase bone mass in women with osteoporosis due to sustained systemic glucocorticoid therapy treatment of bone loss associated with hormone ablation in men with prostate cancer treatment of bone loss in women with breast cancer treatment of giant cell tumor of bone treatment of hypercalcemia of malignancy treatment of multiple myeloma treatment of bone metastases in men with prostate cancer treatment of bone metastases in women with breast cancer.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}